Forcyte Biotechnologies Analysis
What is Forcyte Biotechnologies?
Forcyte Biotechnologies specializes in mechanobiology, integrating genomics and pharmacology to enhance mechanical cell function for developing more effective therapies.
Founded
2017
Revenue
<$5M
Company Stage
Seed
YC Batch
W21
Product Features & Capabilities
- FLECS tissuoid contraction assays, FLECS single-cell contractility assays, custom FLECS substrate development, mechanobiology dataset, drug discovery platform for small molecules, mapping genomics and pharmacology to mechanical cell function.
Who are the founders of Forcyte Biotechnologies
IP
Ivan Pushkarsky
CEO and Co-founder
DD
Dino Di Carlo
Co-founder
Investors
- Y Combinator
- Milestone Partners
- Acequia Capital
- Jude Gomila
- Pioneer Fund
- Bali Venture Partners
- Sprint VC
See something that needs updating? Suggest edits to this profile.